Innovations for asthma diagnosis

The latest generation of aserosol exposure systems facilitating the diagnosis of asthma, the SCL GenaSICTM was officially launched by the Québec company SCL Medtech Inc. The IRSST assigned a licence for the use of its patent so that the company could create an improved version of the system compliant with current standards. The federal and provincial governments both contributed financially to this project.